News & Updates
Filter by Specialty:
Intensive BP-lowering a no-go after reperfusion in ischaemic stroke
An intensive blood pressure target (<120 mm Hg) should be avoided in patients who have undergone endovascular thrombectomy for acute ischaemic stroke (AIS) for large-vessel occlusion (LVO), results of the phase III ENCHANTED2/MT* trial showed.
Intensive BP-lowering a no-go after reperfusion in ischaemic stroke
14 Nov 2022
Prasugrel on par with clopidogrel in reducing stroke recurrence in thrombotic stroke patients
In thrombotic stroke patients at high risk of ischaemic stroke recurrence, prasugrel was as effective as clopidogrel in reducing the composite incidence of ischaemic stroke, MI, and death from other vascular causes, the phase III PRASTRO-III study has shown.
Prasugrel on par with clopidogrel in reducing stroke recurrence in thrombotic stroke patients
11 Nov 2022
Arterial stiffness predicts survival in stroke patients
Aortic stiffness, pressure wave reflections (PWRs), and their combined incremental value play pivotal roles in predicting long-term survival, morbidity, and functional disability in patients with acute stroke, suggest the results of a study.
Arterial stiffness predicts survival in stroke patients
07 Nov 2022
Nelonemdaz safe but fails to improve outcomes in stroke
Treatment with nelonemdaz, a multitarget neuroprotectant that selectively blocks N-methyl-D-aspartate receptors and scavenges free radicals, does not appear to significantly improve stroke outcomes as compared with placebo, although nelonemdaz-treated patients show a greater tendency toward achieving modified Rankin Scale scores of 0–2 at 12 weeks, according to the results of a phase II study.
